Arthur Sadoun warns of ‘very tough days’ ahead as Publicis fights to return to growth

Arthur Sadoun, chief executive and chairman of Publicis Groupe, has warned that there are still.

Excerpt: Health media in the COVID-19 era

For a feature set to be published in the July/August issue of MM&M, we reached.

Pharma brands tweak media mix to align with their stance on racism

Numerous drug makers publicly expressed solidarity with Black Americans in the wake of the killings.

Publicis reveals diversity data and outlines 7 actions to improve equality

Publicis Group has vowed to take seven actions toward a more inclusive workplace. CEO Arthur.

Novartis, Pfizer among drug makers giving thumbs-up to Facebook ad boycott

Several drugmakers have signed onto the July #StopHateForProfit Facebook ad boycott and dozens of pharma.

Organic Healthcare Marketing: To DIY or Not to DIY?

Eventually, every digital marketing specialist hears this phrase from a current or would-be client: “We.

Gilead names remdesivir price

Gilead has named the price for its experimental COVID-19 treatment, remdesivir. There are several prices.

Point of care and the pandemic

At the start of 2020, individuals and organizations heavily invested in the point-of-care channel had.

Coronavirus Briefing: The marketing/communications community, eldercare issues and damning data

Prior to each of the roughly 472 viewings of Paddington 2 in my house during.

Publicis Health revamps internship program into virtual summer academy in light of pandemic

As students around the world face canceled internships or summer jobs, Publicis Health has reinvented.